NO20041848L - Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater - Google Patents

Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater

Info

Publication number
NO20041848L
NO20041848L NO20041848A NO20041848A NO20041848L NO 20041848 L NO20041848 L NO 20041848L NO 20041848 A NO20041848 A NO 20041848A NO 20041848 A NO20041848 A NO 20041848A NO 20041848 L NO20041848 L NO 20041848L
Authority
NO
Norway
Prior art keywords
mandible
salts
new
tetrahydrofuran derivatives
substituted tetracyclic
Prior art date
Application number
NO20041848A
Other languages
English (en)
Other versions
NO328548B1 (no
Inventor
Johannes Josephus Mari Willems
Bart Petrus Anna Maria Medaer
Sigrid Carl Maria Stokbroekx
Yves Georges Ruysschaert
Johan Erwin Edmond Weerts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20041848L publication Critical patent/NO20041848L/no
Publication of NO328548B1 publication Critical patent/NO328548B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20041848A 2001-11-09 2004-05-05 Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater NO328548B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204465 2001-11-09
PCT/EP2002/011136 WO2003040122A1 (en) 2001-11-09 2002-11-08 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives

Publications (2)

Publication Number Publication Date
NO20041848L true NO20041848L (no) 2004-05-05
NO328548B1 NO328548B1 (no) 2010-03-15

Family

ID=8181272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041848A NO328548B1 (no) 2001-11-09 2004-05-05 Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater

Country Status (25)

Country Link
US (1) US7317115B2 (no)
EP (1) EP1446397B1 (no)
JP (1) JP2005508988A (no)
KR (1) KR100962325B1 (no)
CN (1) CN1582282B (no)
AR (1) AR037285A1 (no)
AT (1) ATE299138T1 (no)
AU (1) AU2002349327B2 (no)
BR (1) BR0212770A (no)
CA (1) CA2465043C (no)
DE (1) DE60204982T2 (no)
EA (1) EA006980B1 (no)
ES (1) ES2244818T3 (no)
HR (1) HRP20040395A2 (no)
HU (1) HUP0402224A3 (no)
IL (2) IL161866A0 (no)
MX (1) MXPA04004365A (no)
MY (1) MY128237A (no)
NO (1) NO328548B1 (no)
NZ (1) NZ531739A (no)
PL (1) PL368456A1 (no)
TW (1) TW200407117A (no)
UA (1) UA79248C2 (no)
WO (1) WO2003040122A1 (no)
ZA (1) ZA200403454B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
CN1293066C (zh) * 2001-12-07 2007-01-03 詹森药业有限公司 反式稠合的3,3a,8,12b－四氢－2H－二苯并[3,4∶6,7]环庚三烯并[1,2－b]呋喃衍生物的制备
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties
AU2005313325C1 (en) 2004-12-07 2011-11-10 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
JP4937141B2 (ja) 2005-01-27 2012-05-23 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｃｎｓ障害の処置における５ｈｔ２インヒビターとしての複素環式四環式テトラヒドロフラン誘導体
US8569267B2 (en) 2005-06-17 2013-10-29 Janssen Pharmaceutica, Nv Tetracyclic tetrahydrofuran derivatives containing cyclic amine side chain
US8765223B2 (en) * 2008-05-08 2014-07-01 Air Products And Chemicals, Inc. Binary and ternary metal chalcogenide materials and method of making and using same
US8507040B2 (en) 2008-05-08 2013-08-13 Air Products And Chemicals, Inc. Binary and ternary metal chalcogenide materials and method of making and using same
US8962675B1 (en) * 2013-09-12 2015-02-24 Abbvie Inc. Atrasentan mandelate salts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3644462A1 (de) 1986-12-24 1988-07-07 Basf Ag Verfahren zur herstellung von 5h-dibenzo(a,d)cyclohepten-5-onen
JP2656720B2 (ja) * 1992-12-09 1997-09-24 武田薬品工業株式会社 光学活性アミノクマラン誘導体
DE69521122T2 (de) * 1994-03-16 2002-03-07 Cenes Ltd., Cambridge 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
PT892793E (pt) * 1996-04-12 2003-08-29 Janssen Pharmaceutica Nv Derivados 2-cianoiminoimidazolo inibidores da pde iv
KR19990044257A (ko) 1996-05-20 1999-06-25 디르크 반테 생체이용율이 개선된 항진균성 조성물
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US6281247B1 (en) * 1998-03-03 2001-08-28 Novo Nordisk A/S Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide
HUP9904624A2 (hu) * 1999-12-17 2002-01-28 Sanofi-Synthelabo Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik
EP1186303A3 (en) * 2000-09-06 2003-12-10 Pfizer Products Inc. Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist

Also Published As

Publication number Publication date
IL161866A (en) 2010-04-29
CN1582282A (zh) 2005-02-16
US7317115B2 (en) 2008-01-08
CA2465043A1 (en) 2003-05-15
WO2003040122A1 (en) 2003-05-15
PL368456A1 (en) 2005-03-21
UA79248C2 (en) 2007-06-11
EA006980B1 (ru) 2006-06-30
ATE299138T1 (de) 2005-07-15
EA200400656A1 (ru) 2004-10-28
HUP0402224A2 (hu) 2005-02-28
TW200407117A (en) 2004-05-16
MXPA04004365A (es) 2004-08-11
JP2005508988A (ja) 2005-04-07
AR037285A1 (es) 2004-11-03
KR100962325B1 (ko) 2010-06-11
IL161866A0 (en) 2005-11-20
NZ531739A (en) 2005-02-25
NO328548B1 (no) 2010-03-15
EP1446397B1 (en) 2005-07-06
CN1582282B (zh) 2012-06-06
KR20050044310A (ko) 2005-05-12
BR0212770A (pt) 2004-10-13
ZA200403454B (en) 2005-08-31
DE60204982D1 (de) 2005-08-11
EP1446397A1 (en) 2004-08-18
CA2465043C (en) 2011-02-15
US20050085533A1 (en) 2005-04-21
HRP20040395A2 (en) 2005-04-30
MY128237A (en) 2007-01-31
ES2244818T3 (es) 2005-12-16
DE60204982T2 (de) 2006-04-27
HUP0402224A3 (en) 2007-05-29
AU2002349327B2 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
ATE441650T1 (de) Spirocyclische cyclohexan-derivate
NO20034970D0 (no) Nye arylheteroalkylaminderivater
NO20043660L (no) Salter av valsartan
NO20050072L (no) Nye inhibitorer av kinaser
NO20044003L (no) Krystallisk mikronisat av tiotropiumbromid
ATE428701T1 (de) Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
SE0203693L (sv) Styrning av steriliseringsanordning
NO20010619D0 (no) Krystallin base av citalopram
CY2017048I2 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
DK1697379T3 (da) Spirocykliske cyklohexan-derivater
NO20052474D0 (no) Amort form av esomeprazolsalter
NO20041848L (no) Nye mandelatsalter av substituerte tetracykliske tetrahydrofuranderivater
NO20030657L (no) Nye aminocykloheksanderivater
NO20035248D0 (no) Nye fenylalkyloksy-fenyl derivater
DK1534391T3 (da) Nye piperazinyl-pyrazinonderivater til behandling af 5-HT2A-recptor-relaterede forstyrrelser
NO20041370L (no) Nye vannfrie krystallinske former av gabapentin
DK1631575T3 (da) Nye 3-decladinosyl-9a-N-carbamoyl- og 9a-N-thiocarbamoylderivater af 9-deox-9-dihydro-9a-AZA-9A-homoerythromycin A
NO20051617D0 (no) Piperidinderivater av heterocyklusfusjonerte benzodioksaner med antidepressiv aktivitet
NO20050183L (no) Farmasoytiske salter av reboxetin
DE60200407D1 (de) Methylendioxy- Derivate
NO20025475L (no) Nye benzotiofenderivater
NO20035672D0 (no) Nye indolderivater
DK1440067T3 (da) N-formyl-derivater af paroxetin
DK1608381T3 (da) En sammensætnings nye terapeutiske anvendelse
NO20004364L (no) Nye saltformer av (2E)-5-amino-5-metylheks-2-ensyre-N-metyl-N-

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

MM1K Lapsed by not paying the annual fees